Heestermans, A., Hermanides, R., Gosselink, A., de Boer, M., Hoorntje, J., Suryapranata, H., . . . van ’t Hof, A. (2010). A comparison between upfront high-dose tirofiban versus provisional use in the real-world of non-selected STEMI patients undergoing primary PCI: Insights from the Zwolle acute myocardial infarction registry. Bohn Stafleu van Loghum.
Styl ChicagoHeestermans, A.A.C.M., et al. A Comparison between Upfront High-dose Tirofiban Versus Provisional Use in the Real-world of Non-selected STEMI Patients Undergoing Primary PCI: Insights From the Zwolle Acute Myocardial Infarction Registry. Bohn Stafleu van Loghum, 2010.
Citace podle MLAHeestermans, A.A.C.M., et al. A Comparison between Upfront High-dose Tirofiban Versus Provisional Use in the Real-world of Non-selected STEMI Patients Undergoing Primary PCI: Insights From the Zwolle Acute Myocardial Infarction Registry. Bohn Stafleu van Loghum, 2010.